Nanette Cocero - 08 May 2023 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Director
Signature
/s/ Paul Bavier, Attorney-in-fact
Issuer symbol
HLVX
Transactions as of
08 May 2023
Net transactions value
$0
Form type
4
Filing time
10 May 2023, 17:41:00 UTC
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLVX Stock Option (Right to Buy) Award $0 +34,000 $0.000000 34,000 08 May 2023 Common Stock 34,000 $14.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable in substantially equal monthly installments over three years, commencing on May 8, 2023, subject to the reporting person's continued service on the board of directors of the Issuer through each such vesting date..